SCHEMBL10299526

SCHEMBL10299526

CNCC(C)(C)CC(C)(C)N(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18714771 0.79
SCHEMBL13559807 0.78
SCHEMBL18487367 0.75
SCHEMBL5268956 0.72
SCHEMBL22781257 0.71
SCHEMBL5210963 0.71
SCHEMBL7865959 0.70 TSHR (0.32)
SCHEMBL15027010 0.69
SCHEMBL20281973 0.69 TSHR (0.37)
SCHEMBL22222099 0.69 GRM4 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024092086-A1 COMPOSITIONS AND METHODS FOR REGENERATING CORNEAL ENDOTHELIUM THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2024-05-02 WO disclosed
US-20230150921-A1 PHENOLIC ACID LIPID BASED CATIONIC LIPIDS TRANSLATE BIO, INC. (US) 2023-05-18 US disclosed
EP-3357931-B1 METHODS OF SYNTHESIS OF TRITERPENE PROSAPOGENINS AND TRITERPENE SAPONINS SLOAN KETTERING INST CANCER RES (US) 2020-07-22 EP disclosed
US-20120172411-A1 NOVEL TRIALKYL CATIONIC LIPIDS AND METHODS OF USE THEREOF PROTIVA BIOTHERAPEUTICS, INC. (CA) 2012-07-05 US disclosed